Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, JEAN CHRISTOPHE, holds the title of Director at RHYTHM PHARMACEUTICALS, INC..
On 2026-11-17, the insider transacted 20,000 shares.The shares were transacted at a weighted average price of $72.27 per share, resulting in a total market-relevant value of $1.4M.
JEAN CHRISTOPHE (Director) sold $1.4M of $RYTM
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.